Biosafety (Policy 5080)

University Policy 5080

Download a Printable Version of Policy 5080


Effective Date

January 1992

Last Revision Date

January 2014

Responsible Party

Vice President for Research and Economic Development, (208) 426-5732
Office of Research Compliance, (208) 426-5401

Scope and Audience

This policy applies to funded and unfunded research and academic activities involving biohazardous material.

Additional Authority

  • Centers for Disease Control and Prevention – Biosafety in Microbiological and Biomedical Laboratories – 5th edition and subsequent revisions.
  • Idaho Division of Building Safety – Bloodborne Pathogens, 330
  • National Institutes of Health – NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) – 59 FR 34472 and subsequent amendments.
  • Occupational Safety and Health Administration – Bloodborne Pathogens,
    29 CFR 1910.1030.

1. Policy Purpose

To establish authority and responsibilities of the University, Institutional Biosafety Committee, and Principal Investigators conducting funded and unfunded research and academic activities involving biohazardous material.

2. Policy Statement

The possession and utilization of hazardous materials is essential to Boise State University’s research enterprise. Therefore, Boise State is committed to following the guidance of and fulfilling the obligations set forth by the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and other applicable agencies regarding the safe handling of biohazardous material.

3. Definitions

3.1 Biohazardous Material

An infectious agent or biological material presenting a risk to the health of humans, animals, or other forms of life such as: certain types of DNA, recombinant DNA and synthetic nucleic acid molecules; bloodborne pathogens; infectious organisms and viruses; select agents; and biological toxins.

3.2 Recombinant DNA

Molecules constructed outside a living cell by joining natural or synthetic DNA/RNA segments to DNA/RNA molecules that can replicate in a living cell.

4. Responsibilities and Procedures

4.1 Vice President for Research and Economic Development

The Vice President for Research and Economic Development has delegated certain responsibilities to the Institutional Biosafety Committee (IBC) to ensure compliance with the University’s regulatory obligations and to the Office of Research Compliance (ORC) for support and oversight of the IBC. The Vice President for Research and Economic Development appoints IBC members to ensure appropriate composition and representation in accordance with federal guidelines and committee effectiveness.

4.2 The Institutional Biosafety Committee (IBC)

a. Generally, the IBC is responsible for the review and approval of funded and unfunded research and academic activities involving biohazardous material to assist the university and Principal Investigators (PIs) in adhering to these regulatory requirements and guidelines.

b. Specifically, the IBC has the following authority and responsibilities:

(i.) Review activities involving biohazardous material and determine appropriate level of review based upon the material, activity, and associated risk as outlined in the IBC Program Guide;

(ii.) Approve, not approve, or require modification of activities involving biohazardous material to ensure compliance with regulatory obligations and University policies and programs;

(iii.) Report approval status in accordance with agency requirements; and

(iv.) Report non-compliance to the Vice President for Research and Economic Development (through the ORC) and appropriate agencies as required.

(v.) Suspend or terminate activity approval based upon non-compliance with regulatory obligations and University policies and programs.

4.3 Office of Research Compliance

The ORC provides administrative support and oversight of the IBC, which includes maintaining official records and developing program guidance, forms, and procedures.

4.4 Principle Investigator

a. Sufficiently complete and submit applicable forms to the IBC for activities requiring review;

b. Abstain from performing activities requiring IBC approval where approval is not granted;

c. Ensure activities under their direction adhere to the scope and procedures approved by the IBC; and

d. Communicate risks associated with the activity to individuals with potential exposure to any associated hazards.


Revision History

July 1995; November 1999; January 2014